| Year |
Citation |
Score |
| 2019 |
Lu YC, Chu T, Hall MS, Fu DJ, Shi Q, Chiu A, An D, Wang LH, Pardo Y, Southard T, Danko CG, Liphardt J, Nikitin AY, Wu M, Fischbach C, et al. Physical confinement induces malignant transformation in mammary epithelial cells. Biomaterials. 217: 119307. PMID 31271857 DOI: 10.1016/J.Biomaterials.2019.119307 |
0.309 |
|
| 2018 |
Carling D, Penfold L, Woods A, Muckett P, Nikitin AY, Kent TR, Zhang S, Graham R, Pollard A. CAMKK2 promotes prostate cancer independently of AMPK via increased lipogenesis. Cancer Research. PMID 30242113 DOI: 10.1158/0008-5472.Can-18-0585 |
0.321 |
|
| 2014 |
Flesken-Nikitin A, Odai-Afotey AA, Nikitin AY. Role of the stem cell niche in the pathogenesis of epithelial ovarian cancers. Molecular & Cellular Oncology. 1: e963435. PMID 27308341 DOI: 10.4161/23723548.2014.963435 |
0.332 |
|
| 2014 |
Cheng CY, Hwang CI, Corney DC, Flesken-Nikitin A, Jiang L, Oner GM, Munroe RJ, Schimenti JC, Hermeking H, Nikitin AY. miR-34 cooperates with p53 in suppression of prostate cancer by joint regulation of stem cell compartment. Cell Reports. 6: 1000-7. PMID 24630988 DOI: 10.1016/J.Celrep.2014.02.023 |
0.731 |
|
| 2014 |
Cui M, Augert A, Rongione M, Conkrite K, Parazzoli S, Nikitin AY, Ingolia N, MacPherson D. PTEN is a potent suppressor of small cell lung cancer. Molecular Cancer Research : McR. 12: 654-9. PMID 24482365 DOI: 10.1158/1541-7786.Mcr-13-0554 |
0.303 |
|
| 2012 |
Chandler EM, Seo BR, Califano JP, Andresen Eguiluz RC, Lee JS, Yoon CJ, Tims DT, Wang JX, Cheng L, Mohanan S, Buckley MR, Cohen I, Nikitin AY, Williams RM, Gourdon D, et al. Implanted adipose progenitor cells as physicochemical regulators of breast cancer. Proceedings of the National Academy of Sciences of the United States of America. 109: 9786-91. PMID 22665775 DOI: 10.1073/Pnas.1121160109 |
0.595 |
|
| 2012 |
HogenEsch H, Nikitin AY. Challenges in pre-clinical testing of anti-cancer drugs in cell culture and in animal models. Journal of Controlled Release : Official Journal of the Controlled Release Society. 164: 183-6. PMID 22446384 DOI: 10.1016/j.jconrel.2012.02.031 |
0.312 |
|
| 2011 |
Hwang CI, Choi J, Zhou Z, Flesken-Nikitin A, Tarakhovsky A, Nikitin AY. MET-dependent cancer invasion may be preprogrammed by early alterations of p53-regulated feedforward loop and triggered by stromal cell-derived HGF. Cell Cycle (Georgetown, Tex.). 10: 3834-40. PMID 22071625 DOI: 10.4161/Cc.10.22.18294 |
0.455 |
|
| 2011 |
Hwang CI, Matoso A, Corney DC, Flesken-Nikitin A, Körner S, Wang W, Boccaccio C, Thorgeirsson SS, Comoglio PM, Hermeking H, Nikitin AY. Wild-type p53 controls cell motility and invasion by dual regulation of MET expression. Proceedings of the National Academy of Sciences of the United States of America. 108: 14240-5. PMID 21831840 DOI: 10.1073/Pnas.1017536108 |
0.723 |
|
| 2011 |
Sun H, Wang Y, Chinnam M, Zhang X, Hayward SW, Foster BA, Nikitin AY, Wills M, Goodrich DW. E2f binding-deficient Rb1 protein suppresses prostate tumor progression in vivo. Proceedings of the National Academy of Sciences of the United States of America. 108: 704-9. PMID 21187395 DOI: 10.1073/Pnas.1015027108 |
0.353 |
|
| 2010 |
Cheng L, Zhou Z, Flesken-Nikitin A, Toshkov IA, Wang W, Camps J, Ried T, Nikitin AY. Rb inactivation accelerates neoplastic growth and substitutes for recurrent amplification of cIAP1, cIAP2 and Yap1 in sporadic mammary carcinoma associated with p53 deficiency. Oncogene. 29: 5700-11. PMID 20676140 DOI: 10.1038/Onc.2010.300 |
0.605 |
|
| 2010 |
Liu K, Cheng L, Flesken-Nikitin A, Huang L, Nikitin AY, Pauli BU. Conditional knockout of fibronectin abrogates mouse mammary gland lobuloalveolar differentiation. Developmental Biology. 346: 11-24. PMID 20624380 DOI: 10.1016/J.Ydbio.2010.07.001 |
0.551 |
|
| 2010 |
Sarveswaran S, Liroff J, Zhou Z, Nikitin AY, Ghosh J. Selenite triggers rapid transcriptional activation of p53, and p53-mediated apoptosis in prostate cancer cells: Implication for the treatment of early-stage prostate cancer. International Journal of Oncology. 36: 1419-28. PMID 20428765 |
0.436 |
|
| 2010 |
Corney DC, Hwang CI, Matoso A, Vogt M, Flesken-Nikitin A, Godwin AK, Kamat AA, Sood AK, Ellenson LH, Hermeking H, Nikitin AY. Frequent downregulation of miR-34 family in human ovarian cancers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 1119-28. PMID 20145172 DOI: 10.1158/1078-0432.Ccr-09-2642 |
0.722 |
|
| 2010 |
Li B, Antonyak MA, Druso JE, Cheng L, Nikitin AY, Cerione RA. EGF potentiated oncogenesis requires a tissue transglutaminase-dependent signaling pathway leading to Src activation. Proceedings of the National Academy of Sciences of the United States of America. 107: 1408-13. PMID 20080707 DOI: 10.1073/Pnas.0907907107 |
0.617 |
|
| 2010 |
Cheng L, Ramesh AV, Flesken-Nikitin A, Choi J, Nikitin AY. Mouse models for cancer stem cell research. Toxicologic Pathology. 38: 62-71. PMID 19920280 DOI: 10.1177/0192623309354109 |
0.608 |
|
| 2008 |
Corney DC, Nikitin AY. MicroRNA and ovarian cancer. Histology and Histopathology. 23: 1161-9. PMID 18581287 DOI: 10.14670/Hh-23.1161 |
0.719 |
|
| 2008 |
Corney DC, Flesken-Nikitin A, Choi J, Nikitin AY. Role of p53 and Rb in ovarian cancer. Advances in Experimental Medicine and Biology. 622: 99-117. PMID 18546622 DOI: 10.1007/978-0-387-68969-2_9 |
0.725 |
|
| 2008 |
Schug TT, Berry DC, Toshkov IA, Cheng L, Nikitin AY, Noy N. Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARbeta/delta to RAR. Proceedings of the National Academy of Sciences of the United States of America. 105: 7546-51. PMID 18495924 DOI: 10.1073/Pnas.0709981105 |
0.538 |
|
| 2007 |
Corney DC, Flesken-Nikitin A, Godwin AK, Wang W, Nikitin AY. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Research. 67: 8433-8. PMID 17823410 DOI: 10.1158/0008-5472.Can-07-1585 |
0.713 |
|
| 2007 |
Liao CP, Zhong C, Saribekyan G, Bading J, Park R, Conti PS, Moats R, Berns A, Shi W, Zhou Z, Nikitin AY, Roy-Burman P. Mouse models of prostate adenocarcinoma with the capacity to monitor spontaneous carcinogenesis by bioluminescence or fluorescence. Cancer Research. 67: 7525-33. PMID 17671224 DOI: 10.1158/0008-5472.Can-07-0668 |
0.361 |
|
| 2006 |
Zhou Z, Flesken-Nikitin A, Corney DC, Wang W, Goodrich DW, Roy-Burman P, Nikitin AY. Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer. Cancer Research. 66: 7889-98. PMID 16912162 DOI: 10.1158/0008-5472.Can-06-0486 |
0.697 |
|
| 2006 |
Daikoku T, Tranguch S, Trofimova IN, Dinulescu DM, Jacks T, Nikitin AY, Connolly DC, Dey SK. Cyclooxygenase-1 is overexpressed in multiple genetically engineered mouse models of epithelial ovarian cancer. Cancer Research. 66: 2527-31. PMID 16510568 DOI: 10.1158/0008-5472.Can-05-4063 |
0.36 |
|
| 2003 |
Hamilton TC, Connolly DC, Nikitin AY, Garson K, Vanderhyden BC. Translational research in ovarian cancer: A must International Journal of Gynecological Cancer. 13: 220-230. PMID 14656284 DOI: 10.1111/J.1525-1438.2003.13350.X |
0.31 |
|
| 2003 |
Flesken-Nikitin A, Choi KC, Eng JP, Shmidt EN, Nikitin AY. Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium. Cancer Research. 63: 3459-63. PMID 12839925 |
0.36 |
|
| 2003 |
Connolly DC, Bao R, Nikitin AY, Stephens KC, Poole TW, Hua X, Harris SS, Vanderhyden BC, Hamilton TC. Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer. Cancer Research. 63: 1389-97. PMID 12649204 |
0.335 |
|
| 2003 |
Lin S, Lee K, Nikitin A, Bushnell K, Hilsenbeck S, Cardiff R, Li A, Kang K, Frank S, Lee W, Lee E. Estrogen receptor alpha-positive and negative mouse mammary tumors through somatic mutations of p53 in mammary carcinogenesis Breast Cancer Research. 5: 2-2. DOI: 10.1186/Bcr661 |
0.4 |
|
| 1999 |
Nikitin AY, Riley DJ, Lee WH. A paradigm for cancer treatment using the retinoblastoma gene in a mouse model Annals of the New York Academy of Sciences. 886: 12-22. PMID 10667199 DOI: 10.1111/J.1749-6632.1999.TB09396.X |
0.323 |
|
| Show low-probability matches. |
